FRED HUTCHINSON CANCER CENTER
Combination Chemotherapy and Antithymocyte Globulin in Reducing Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplantation For Myelodysplastic Syndrome or Myeloproliferative Disorder
- First Posted Date
- 2003-02-06
- Last Posted Date
- 2010-05-14
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Registration Number
- NCT00054340
- Locations
- ๐บ๐ธ
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Older Patients With Chronic Myeloid Leukemia
- Conditions
- Interventions
- Drug: Fludarabine PhosphateRadiation: Total-Body IrradiationProcedure: Nonmyeloablative Allogeneic Hematopoietic Stem Cell TransplantationProcedure: Peripheral Blood Stem Cell TransplantationDrug: CyclosporineDrug: Mycophenolate MofetilBiological: Therapeutic Allogeneic LymphocytesOther: Laboratory Biomarker Analysis
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2020-01-10
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 18
- Registration Number
- NCT00003145
- Locations
- ๐บ๐ธ
Baylor University Medical Center, Dallas, Texas, United States
๐บ๐ธFred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States
๐บ๐ธStanford University Hospitals and Clinics, Stanford, California, United States
Study of Lung Function in Children Who Have Undergone Bone Marrow Transplantation
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-05-01
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 280
- Registration Number
- NCT00009711
- Locations
- ๐บ๐ธ
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies
- Conditions
- Adult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With t(16;16)(p13;q22)Childhood Myelodysplastic SyndromesChildhood Nasal Type Extranodal NK/T-cell LymphomaAcute Myeloid Leukemia/Transient Myeloproliferative DisorderAdult Nasal Type Extranodal NK/T-cell LymphomaAngioimmunoblastic T-cell LymphomaChildhood Acute Lymphoblastic Leukemia in RemissionChildhood Acute Myeloid Leukemia in RemissionAcute Undifferentiated Leukemia
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2020-01-21
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 160
- Registration Number
- NCT00014235
- Locations
- ๐บ๐ธ
University of Arizona Health Sciences Center, Tucson, Arizona, United States
๐บ๐ธBaylor University Medical Center, Dallas, Texas, United States
๐บ๐ธOHSU Knight Cancer Institute, Portland, Oregon, United States
Valacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell Transplantation
- Conditions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2010-09-21
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Registration Number
- NCT00045292
- Locations
- ๐บ๐ธ
Baylor University Medical Center, Dallas, Texas, United States
๐บ๐ธHuntsman Cancer Institute, Salt Lake City, Utah, United States
๐บ๐ธUNMC Eppley Cancer Center at the University of Nebraska Medical Center, Omaha, Nebraska, United States
Standard Follow-up Compared With Extended Follow-up in Treating Patients Who Have Undergone Stem Cell Transplantation for Cancer
- Conditions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2010-09-21
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Registration Number
- NCT00049465
- Locations
- ๐บ๐ธ
Huntsman Cancer Institute, Salt Lake City, Utah, United States
๐บ๐ธStanford University Medical Center, Stanford, California, United States
๐บ๐ธShands Hospital and Clinics, University of Florida, Gainesville, Florida, United States
Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Myeloproliferative Disorder
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2010-09-16
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 30
- Registration Number
- NCT00049634
- Locations
- ๐บ๐ธ
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
๐บ๐ธSeattle Cancer Care Alliance, Seattle, Washington, United States
Biological Therapy After Chemotherapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2010-08-24
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 12
- Registration Number
- NCT00012207
- Locations
- ๐บ๐ธ
Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
๐บ๐ธCity of Hope Comprehensive Cancer Center, Duarte, California, United States
๐บ๐ธUniversity of Washington School of Medicine, Seattle, Washington, United States
Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Stage IV Kidney Cancer
- Conditions
- Interventions
- Drug: fludarabine phosphateRadiation: total-body irradiationProcedure: nonmyeloablative allogeneic hematopoietic stem cell transplantationDrug: cyclosporineDrug: mycophenolate mofetilProcedure: peripheral blood stem cell transplantationBiological: therapeutic allogeneic lymphocytesOther: laboratory biomarker analysis
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2019-07-24
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 11
- Registration Number
- NCT00005851
- Locations
- ๐บ๐ธ
Rocky Mountain Cancer Centers-Aurora, Aurora, Colorado, United States
๐บ๐ธFred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States
๐บ๐ธFroedtert and the Medical College of Wisconsin, Milwaukee, Wisconsin, United States
Melphalan, Peripheral Stem Cell Transplantation, and Interleukin-2 Followed by Interferon Alfa in Treating Patients With Advanced Multiple Myeloma
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2017-07-12
- Lead Sponsor
- Fred Hutchinson Cancer Center
- Target Recruit Count
- 36
- Registration Number
- NCT00006244
- Locations
- ๐บ๐ธ
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States